Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 138 (2) , 352-357
Abstract
No abstract availableKeywords
Funding Information
- RPCI-UPCI Ovarian Cancer SPORE (NIH P50CA159981-01A1, NIH T32CA108456)
- Roswell Park Alliance Foundation
- 2014-2015 Developmental Funds award from the Roswell Park Alliance Foundation
- University at Buffalo School of Medicine Pilot Research Award (K01LM012100)
- NCI Cancer Center Support (CA016056)
This publication has 39 references indexed in Scilit:
- Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axisJournal of Clinical Investigation, 2013
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patientsJournal of Clinical Investigation, 2013
- Paraneoplastic Thrombocytosis in Ovarian CancerNew England Journal of Medicine, 2012
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyBlood, 2012
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cellsJournal of Clinical Investigation, 2011
- Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapyBlood, 2010
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humansJournal of Clinical Investigation, 2009
- The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinomaCancer, 2009
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaJournal of Experimental Medicine, 2006